article thumbnail

Article EMA Thank You New guidance provides definition for orphan device, offers alternative trial designs

Agency IQ

New guidance provides definition for orphan device, offers alternative trial designs New guidance from the European Commission outlines alternatives for full pre-market clinical trials for orphan devices, defined by the Commission for the first time. Does this guidance offer the formal definition of “orphan device” we’ve been waiting for?

Trials 40
article thumbnail

Regulatory Developments in Ophthalmology: Applying New FDA Guidance, Part One

The Premier Consulting Blog

The new guidance provides detailed information to applicants and manufacturers regarding compliance with the requirements in 21 CFR Part 4 for ophthalmic drugs packaged with eye cups, eye droppers, or other dispensers.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Leveraging TypeScript’s Power with Next.js

Perficient: Drug Development

For example: Type Definitions for External Libraries: If you’re using third-party libraries that don’t have built-in typescript support, you can create type definitions for them using. files or by installing community created definitely typed packages. Within a Next.js

article thumbnail

A Comprehensive Guide to Implementing BDD testing in Katalon Studio

Perficient: Drug Development

We will dive into creating a BDD Feature file and Step Definition file in Katalon Studio for a test case and perform execution of the test by two methods: Directly running the Feature file and utilizing in-built Keywords to run it from the Test Case. This article will explore how we can perform BDD testing in Katalon Studio.

article thumbnail

Analysis Chemical Thank You Spurred by NRDC report, California senator proposes state ban on PFAS

Agency IQ

An AgencyIQ explainer on the EPA’s definition of PFAS may be reviewed here.] In the same month, the California Department of Toxic Substances Control (DTSC) presented its chemical profile for carpets and rugs containing PFAS as well as a webinar for its findings on PFAS in food packaging.

article thumbnail

Kubernetes Testing Approaches and Best Practices

Perficient: Drug Development

Kubernetes Testing Approaches Unit Testing: Definition: Unit testing is a software testing approach that focuses on evaluating individual components of a system in isolation. End-to-End Testing: Definition: End-to-end testing is a comprehensive testing approach that evaluates the entire application, including its dependencies.

article thumbnail

Do You Have a Combination Product, and Is It Drug-led or Device-led? Early Regulatory Insights

The Premier Consulting Blog

Determining if you have a combination product The high-level definition of combination product seems straightforward: a product with at least two constituent parts, such as: Drug/biologic (e.g., metered-dose inhaler) However, the four-part definition in 21 CFR 3.2(e) The drug product is packaged and shipped as a solid powder.